BioSpace News Archive

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2021 before the market opens on Wednesday, February 2, 2022, and will hold a conference call on the same day at 8:30 a.m. EST.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to purchase an aggregate of 5,600 shares of Karyopharm’s common stock to 2 newly-hired employees, with a grant date of December 31, 2021.